Reported Earnings • May 05
Full year 2025 earnings released: EPS: US$0.34 (vs US$3.37 in FY 2024) Full year 2025 results: EPS: US$0.34 (down from US$3.37 in FY 2024). Revenue: US$12.2m (down 19% from FY 2024). Net income: US$681.0k (down 67% from FY 2024). Profit margin: 5.6% (down from 14% in FY 2024). The decrease in margin was driven by lower revenue. Announcement • Apr 22
Oriental Rise Holdings Limited Receives Nasdaq Staff Delisting Determination Oriental Rise Holdings Limited announced that it received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 15, 2026, notifying the Company that Nasdaq has determined to delist the Company's ordinary shares from The Nasdaq Capital Market. According to the Determination Letter, Nasdaq determined that the closing bid price of the Company's listed securities had been below $1.00 per share for the previous 30 consecutive business days and that the Company therefore no longer complies with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Nasdaq further stated that, because the Company effected a 1-for-20 reverse stock split on December 30, 2025, the Company is not eligible for the 180-calendar day compliance period that would otherwise be available under Nasdaq Listing Rule 5810(c)(3)(A). Nasdaq has advised the Company that, unless the Company requests a hearing before a Nasdaq Hearings Panel by April 22, 2026, trading in the Company's ordinary shares will be suspended at the opening of business on April 24, 2026, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Company intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. The Company is currently evaluating its options and intends to present a plan to regain compliance with Nasdaq's continued listing requirements. There can be no assurance that the Hearings Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance with the applicable continued listing requirements. New Risk • Mar 18
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 359% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 27% per year over the past 5 years. Shareholders have been substantially diluted in the past year (359% increase in shares outstanding). Market cap is less than US$10m (US$2.04m market cap). Minor Risk Profit margins are more than 30% lower than last year (0.04% net profit margin). 
